Drug Profile
MK 0731
Alternative Names: MK-0731Latest Information Update: 17 Mar 2010
Price :
$50
*
At a glance
- Originator Merck & Co
- Class Amides; Antineoplastics; Piperidines; Pyrroles
- Mechanism of Action KIF11 protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Solid tumours